Eirik Bratland Selected Research

Combined Modality Therapy

1/2020

Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eirik Bratland Research Topics

Disease

14	Addison Disease (Addison's Disease) 12/2022 - 05/2006
4	type 1 Autoimmune polyendocrinopathy syndrome 12/2022 - 06/2013
2	Immune System Diseases (Immune Disorders) 12/2022 - 06/2014
2	Autoimmune Diseases (Autoimmune Disease) 11/2021 - 01/2021
2	Infections 08/2018 - 03/2016
2	Dental Enamel Hypoplasia 01/2016 - 06/2013
1	Familial Exudative Vitreoretinopathies 02/2024
1	Primary Ovarian Insufficiency 11/2023
1	Intellectual Disability (Idiocy) 11/2023
1	Endocrine System Diseases (Endocrine Diseases) 12/2022
1	Deficiency Diseases (Deficiency Disease) 12/2022
1	Hypopituitarism (Sheehan's Syndrome) 01/2022
1	Holoprosencephaly (Arhinencephaly) 01/2022
1	Neoplasms (Cancer) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Hyperandrogenism 01/2019
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2019
1	Giardiasis 08/2018
1	Persistent Infection 08/2018
1	Chronic Mucocutaneous Candidiasis 01/2017
1	Mycoses (Diseases, Fungus) 01/2017
1	Hypoparathyroidism 01/2016
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016
1	Seizures (Absence Seizure) 12/2015
1	Intestinal Hypomagnesemia 1 12/2015
1	Hypocalcemia 12/2015
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2014
1	Adrenocortical Carcinoma 01/2013
1	Virus Diseases (Viral Diseases) 01/2013

Drug/Important Bio-Agent (IBA)

9	AutoantibodiesIBA 11/2023 - 08/2009
8	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 04/2021 - 05/2006
4	SteroidsIBA 11/2023 - 08/2009
4	InterferonsIBA 03/2016 - 01/2013
3	AntigensIBA 11/2023 - 04/2011
3	CytokinesIBA 12/2022 - 01/2013
3	EnzymesIBA 04/2021 - 05/2006
3	EpitopesIBA 01/2021 - 12/2009
3	AntibodiesIBA 08/2018 - 06/2013
3	AutoantigensIBA 12/2014 - 05/2006
2	Interferon Type IIBA 12/2022 - 07/2014
2	InterleukinsIBA 12/2022 - 01/2017
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2009 - 08/2009
1	Retinaldehyde (Retinal)IBA 02/2024
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2021
1	Biomarkers (Surrogate Marker)IBA 03/2021
1	GlucocorticoidsIBA 03/2021
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	MethyltransferasesIBA 01/2020
1	Toll-Like Receptor 3IBA 04/2019
1	PregnenoloneIBA 01/2019
1	Dehydroepiandrosterone SulfateIBA 01/2019
1	Dehydroepiandrosterone (DHEA)IBA 01/2019
1	SaltsIBA 01/2019
1	Immunoglobulin G (IgG)IBA 08/2018
1	Immunoglobulin A (IgA)IBA 08/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2017
1	Interleukin-23 (Interleukin 23)IBA 01/2017
1	MagnesiumIBA 12/2015
1	ChemokinesIBA 10/2015
1	Interleukin-2 (IL2)IBA 03/2015
1	Hormones (Hormone)IBA 06/2014
1	Aromatic Amino Acids (Aromatic Amino Acid)IBA 06/2013
1	Tryptophan HydroxylaseIBA 06/2013
1	Mixed Function Oxygenases (Monooxygenases)IBA 06/2013
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 06/2013
1	LigandsIBA 01/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013
1	Poly I-CIBA 01/2013
1	CXC ChemokinesIBA 01/2013
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2009
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2009
1	Amino Acids FDA Link 12/2009
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 05/2006

Therapy/Procedure

1	Combined Modality Therapy 01/2020
1	Therapeutics 04/2011